Search research articles
Contact Us
Filters
Showing results (151-160 of 188) with videos related to
Page
of 19
Sort By:
European Journal of Immunology
|
January 1, 1988
Genetic regulation of multispecific antibody responsiveness: improvement of "high" and "low" characters
D Mouton, M Siqueira, O A Sant'Anna, et al.
Psychological Research
|
January 23, 2021
"Speak of the Devil… and he Shall Appear": Religiosity, Unconsciousness, and the Effects of Explicit Priming in the Misperception of Immorality
Myron Tsikandilakis, Man Qing Leong, Zhaoliang Yu, et al.
Annals of the New York Academy of Sciences
|
July 17, 2010
Urotensin II, from fish to human
Hubert Vaudry, Jean-Claude Do Rego, Jean-Claude Le Mevel, et al.
Scientific Reports
|
December 12, 2019
O-GlcNAc stimulation: A new metabolic approach to treat septic shock
Marine Ferron, Julien Cadiet, Antoine Persello, et al.
Elife
|
October 7, 2020
RUNX1 marks a luminal castration-resistant lineage established at the onset of prostate development
Renaud Mevel, Ivana Steiner, Susan Mason, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 6, 2000
Salvage extended-field irradiation in follicular non-Hodgkin's lymphoma after failure of chemotherapy
M a Mahé, S Bourdin, A Le Pourhiet-Le Mevel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1997
Is the International Prognostic Index for aggressive lymphomas useful for low-grade lymphoma patients? Applicability to stage III-IV patients. The GOELAMS Group, France
C Foussard, B Desablens, L Sensebe, et al.
Eneuro
|
March 13, 2018
Sulcal Polymorphisms of the IFC and ACC Contribute to Inhibitory Control Variability in Children and Adults
Cloélia Tissier, Adriano Linzarini, Geneviève Allaire-Duquette, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1978
Prognostic factors and treatment of multiple myeloma: interest of a cyclic sequential chemohormonotherapy combining cyclophosphamide, melphalan, and prednisone
D Belpomme, F Simon, P Pouillart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series
J Y Blay, T Conroy, C Chevreau, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 188) with videos related to
Sort By:
Page
of 19
European Journal of Immunology
|
January 1, 1988
Genetic regulation of multispecific antibody responsiveness: improvement of "high" and "low" characters
D Mouton, M Siqueira, O A Sant'Anna, et al.
Psychological Research
|
January 23, 2021
"Speak of the Devil… and he Shall Appear": Religiosity, Unconsciousness, and the Effects of Explicit Priming in the Misperception of Immorality
Myron Tsikandilakis, Man Qing Leong, Zhaoliang Yu, et al.
Annals of the New York Academy of Sciences
|
July 17, 2010
Urotensin II, from fish to human
Hubert Vaudry, Jean-Claude Do Rego, Jean-Claude Le Mevel, et al.
Scientific Reports
|
December 12, 2019
O-GlcNAc stimulation: A new metabolic approach to treat septic shock
Marine Ferron, Julien Cadiet, Antoine Persello, et al.
Elife
|
October 7, 2020
RUNX1 marks a luminal castration-resistant lineage established at the onset of prostate development
Renaud Mevel, Ivana Steiner, Susan Mason, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 6, 2000
Salvage extended-field irradiation in follicular non-Hodgkin's lymphoma after failure of chemotherapy
M a Mahé, S Bourdin, A Le Pourhiet-Le Mevel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1997
Is the International Prognostic Index for aggressive lymphomas useful for low-grade lymphoma patients? Applicability to stage III-IV patients. The GOELAMS Group, France
C Foussard, B Desablens, L Sensebe, et al.
Eneuro
|
March 13, 2018
Sulcal Polymorphisms of the IFC and ACC Contribute to Inhibitory Control Variability in Children and Adults
Cloélia Tissier, Adriano Linzarini, Geneviève Allaire-Duquette, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1978
Prognostic factors and treatment of multiple myeloma: interest of a cyclic sequential chemohormonotherapy combining cyclophosphamide, melphalan, and prednisone
D Belpomme, F Simon, P Pouillart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series
J Y Blay, T Conroy, C Chevreau, et al.
Page
of 19